Eton Pharmaceuticals (ETON) Non-Current Assets (2017 - 2025)

Eton Pharmaceuticals has disclosed Non-Current Assets across 9 years of filings, most recently posting $31.5 million for Q4 2025.

• Non-Current Assets for Q4 2025 came in at $31.5 million, down 10.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $131.3 million (up 142.72% YoY), and the FY2025 annual result was $31.5 million, down 10.17% from the prior year.
• Non-Current Assets came in at $31.5 million for Q4 2025 at Eton Pharmaceuticals, down from $32.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $35.1 million in Q4 2024 to a low of $743000.0 in Q3 2021.
• The 5-year median for Non-Current Assets is $5.0 million (2022), against an average of $11.4 million.
• Across the five-year window, Non-Current Assets sank 53.85% in 2021 and jumped 616.22% in 2024, its largest moves.
• Eton Pharmaceuticals' Non-Current Assets stood at $3.9 million in 2021, then jumped by 30.17% to $5.0 million in 2022, then slipped by 2.49% to $4.9 million in 2023, then surged by 616.22% to $35.1 million in 2024, then fell by 10.17% to $31.5 million in 2025.
• The last three Non-Current Assets figures came in at $31.5 million (Q4 2025), $32.5 million (Q3 2025), and $33.2 million (Q2 2025), per Business Quant data.